Iodamide: Difference between revisions
m Protected "Iodamide": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
Line 2: | Line 2: | ||
{{SI}} | {{SI}} | ||
Line 8: | Line 8: | ||
[[Category:Drugs]] | [[Category:Drugs]] |
Revision as of 16:32, 9 August 2012
WikiDoc Resources for Iodamide |
Articles |
---|
Most recent articles on Iodamide |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Iodamide at Clinical Trials.gov Clinical Trials on Iodamide at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Iodamide
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Iodamide Risk calculators and risk factors for Iodamide
|
Healthcare Provider Resources |
Causes & Risk Factors for Iodamide |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Iodamide an ionic monomeric contrast medium. The molecular formula is benzoic acid, 3-(acetylamino)-5-((acetylamino)methyl)-2,4,6-triiodo-, and has following equivalent names: Iodamide Sodium; Iodomiron; Odiston; Uromiro.